Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery

Cytokine

Volumn 65, Issue 2, 2014, Pages 153-158

  Ebert, Thomas ^a,b   Stepan, Holger ^a   Schrey, Susanne ^a   Kralisch, Susan ^a,b   Hindricks, Janka ^a,b   Hopf, Lisa ^a,b   Platz, Martin ^a,b   Lossner, Ulrike ^a,b   Jessnitzer, Beate ^a   Drewlo, Sascha ^c   Blüher, Matthias ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gestational diabetes mellitus; Irisin; Myokine; Pregnancy

Indexed keywords

INSULIN; IRISIN; MUSCLE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DOWN REGULATION; ELECTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PATIENT ASSESSMENT; PLACENTA; PREDICTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

MUS;

ADIPOCYTE FATTY ACID-BINDING PROTEIN; AFABP; BMI; BODY MASS-INDEX; C REACTIVE PROTEIN; CRP; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING GLUCOSE; FASTING INSULIN; FFA; FG; FGF-21; FI; FIBROBLAST GROWTH FACTOR-21; FREE FATTY ACIDS; GDM; GESTATIONAL DIABETES MELLITUS; GLYCOSYLATED HEMOGLOBIN A1C; HBA1C; HDL; HIGH DENSITY LIPOPROTEIN; HOMA-IR; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; IRISIN; LDL; LOW DENSITY LIPOPROTEIN; MYOKINE; OGTT; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY; T2DM; TG; TRIGLYCERIDES; TYPE 2 DIABETES MELLITUS; WAIST TO HIP-RATIO; WHR;

ADULT; ANIMALS; CASE-CONTROL STUDIES; DELIVERY, OBSTETRIC; DIABETES, GESTATIONAL; FASTING; FEMALE; FIBRONECTINS; HUMANS; INSULIN; MICE; MULTIVARIATE ANALYSIS; PERIPARTUM PERIOD; POSTPARTUM PERIOD; PREGNANCY; REGRESSION ANALYSIS;

EID: 84892480227     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.11.009     Document Type: Article

References (22)

1. Fadl H.E., Östlund I.K.M., Magnuson A.F.K., Hanson U.S.B. Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med 2010, 27:436-441.
2. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes. Diabet Care 2002, 25:1862-1868.
3. Shah B.R., Retnakaran R., Booth G.L. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabet Care 2008, 31:1668-1669.
4. Hillier T.A., Pedula K.L., Schmidt M.M., Mullen J.A., Charles M.-A., Pettitt D.J. Childhood obesity and metabolic imprinting. Diabet Care 2007, 30:2287-2292.
5. Silverman B.L., Metzger B.E., Cho N.H., Loeb C.A. Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinism. Diabet Care 1995, 18:611-617.
6. Fasshauer M., Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46:1594-1603.
7. Kralisch S., Stepan H., Kratzsch J., Verlohren M., Verlohren H.-J., Drynda K., et al. Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol 2009, 160:33-38.
8. Miehle K., Stepan H., Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol 2012, 76:2-11.
9. Boström P., Wu J., Jedrychowski M.P., Korde A., Ye L., Lo J.C., et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
10. Staiger H., Böhm A., Scheler M., Berti L., Machann J., Schick F., et al. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived "browning" factor irisin, determines insulin sensitivity. PLoS One 2013, 8:e61903.
11. Choi Y.-K., Kim M.-K., Bae K.H., Seo H.-A., Jeong J.-Y., Lee W.-K., et al. Serum irisin levels in new-onset type 2 diabetes. Diabet Res Clin Pract 2013, 100:96-101.
12. Wen M.-S., Wang C.-Y., Lin S.-L., Hung K.-C. Decrease in irisin in patients with chronic kidney disease. PLoS One 2013, 8:e64025.
13. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabet Care 2012, 36:S67-S74.
14. Drewlo S., Czikk M., Baczyk D., Lye S., Kingdom J. Glial cell missing-1 mediates over-expression of tissue inhibitor of metalloproteinase-4 in severe pre-eclamptic placental villi. Hum Reprod 2011, 26:1025-1034.
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
16. Almagor M., Mintz A., Sibirsky O., Durst A. Preoperative and postoperative levels of interleukin-6 in patients with acute appendicitis: comparison between open and laparoscopic appendectomy. Surg Endosc 2005, 19:331-333.
17. Huh J.Y., Panagiotou G., Mougios V., Brinkoetter M., Vamvini M.T., Schneider B.E., et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012, 61:1725-1738.
18. Zhang H.-J., Zhang X.-F., Ma Z.-M., Pan L.-L., Chen Z., Han H.-W., et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol 2013, 59:557-562.
19. Liu J.-J., Wong M.D.S., Toy W.C., Tan C.S.H., Liu S., Ng X.W., et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabet Complicat 2013, 27:365-369.
20. Stengel A., Hofmann T., Goebel-Stengel M., Elbelt U., Kobelt P., Klapp B.F. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index. Peptides 2013, 39:125-130.
21. Moreno-Navarrete J.M., Ortega F., Serrano M., Guerra E., Pardo G., Tinahones F., et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. JCEM 2013, 98:E769-E778.
22. Zhang Y., Scarpace P.J. The role of leptin in leptin resistance and obesity. Physiol Behav 2006, 88:249-256.